Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cimpress (CMPR) Research & Development (2016 - 2025)

Cimpress has reported Research & Development over the past 17 years, most recently at $89.1 million for Q4 2025.

  • Quarterly results put Research & Development at $89.1 million for Q4 2025, up 7.48% from a year ago — trailing twelve months through Dec 2025 was $343.3 million (up 3.26% YoY), and the annual figure for FY2025 was $334.0 million, up 3.75%.
  • Research & Development for Q4 2025 was $89.1 million at Cimpress, up from $84.9 million in the prior quarter.
  • Over the last five years, Research & Development for CMPR hit a ceiling of $89.1 million in Q4 2025 and a floor of $62.6 million in Q1 2021.
  • Median Research & Development over the past 5 years was $79.1 million (2023), compared with a mean of $77.7 million.
  • Biggest five-year swings in Research & Development: rose 20.33% in 2022 and later decreased 10.3% in 2023.
  • Cimpress' Research & Development stood at $70.3 million in 2021, then grew by 10.61% to $77.7 million in 2022, then increased by 2.88% to $80.0 million in 2023, then rose by 3.65% to $82.9 million in 2024, then grew by 7.48% to $89.1 million in 2025.
  • The last three reported values for Research & Development were $89.1 million (Q4 2025), $84.9 million (Q3 2025), and $86.2 million (Q2 2025) per Business Quant data.